Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Sandvik wins major order for underground mining equipment in Portugal PR Newswire STOCKHOLM , July 1, 2024 /PRNewswire/ -- Sandvik has received a major underground mining equipment order from the Portugal -based distributor Cimertex, for delivery to the ...

2024-07-01 07:37:00 ET There's something quite pleasant about having cash deposited into your investment account quarter after quarter and year after year. Here are two outstanding dividend stocks with long histories of rewarding their shareholders with steadily rising cash payments. Bo...

iQIYI Releases Its XR App for Apple Vision Pro PR Newswire BEIJING , July 1, 2024 /PRNewswire/ -- On June 27, iQIYI, a leading online entertainment service in China , announced the launch of its Apple Vision Pro App, iQIYI XR. As one of the first batch o...

2024-07-01 07:33:00 ET This article first appeared on our U.S. website. We can probably all agree that the world will look different in 2034. However, much will likely remain more or less the same as it is today. For example, I expect Nvidia ( NASDAQ: NVDA ) will...

2024-07-01 07:33:00 ET This article first appeared on our U.S. website. We can probably all agree that the world will look different in 2034. However, much will likely remain more or less the same as it is today. For example, I expect Nvidia ( NASDAQ: NVDA ) will...

2024-07-01 07:33:00 ET This article first appeared on our U.S. website. We can probably all agree that the world will look different in 2034. However, much will likely remain more or less the same as it is today. For example, I expect Nvidia ( NASDAQ: NVDA ) will...

2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations

2024-07-01 07:30:04 ET H.C. Wainwright analyst issues NEUTRAL recommendation for SAVA on July 1, 2024 06:07AM ET. The previous analyst recommendation was Buy. SAVA was trading at $12.35 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...

2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH PR Newswire PDUFA Target Action Dates in Late December 2024 Highly Selective CRF 1 Antagonist is the Potent...